Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective

James R Bentham, Jet Neervoort, Timon Louwsma, Lambertus F Wolters, Julie Lyon, Erik J Landaas, Mitesh Nakum

Open source

DOI
10.2147/ceor.s625089
Published
2026-09
Container
ClinicoEconomics and Outcomes Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ceor.s625089,
  title = {Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective},
  author = {James R Bentham and Jet Neervoort and Timon Louwsma and Lambertus F Wolters and Julie Lyon and Erik J Landaas and Mitesh Nakum},
  year = {2026},
  journal = {ClinicoEconomics and Outcomes Research},
  doi = {10.2147/ceor.s625089},
  url = {https://doi.org/10.2147/ceor.s625089}
}

RIS

TY  - JOUR
TI  - Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective
AU  - James R Bentham
AU  - Jet Neervoort
AU  - Timon Louwsma
AU  - Lambertus F Wolters
AU  - Julie Lyon
AU  - Erik J Landaas
AU  - Mitesh Nakum
PY  - 2026
JO  - ClinicoEconomics and Outcomes Research
DO  - 10.2147/ceor.s625089
UR  - https://doi.org/10.2147/ceor.s625089
ER  - 

APA

Bentham, J. R., Neervoort, J., Louwsma, T., Wolters, L. F., Lyon, J., Landaas, E. J., & Nakum, M. (2026). Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective. ClinicoEconomics and Outcomes Research. https://doi.org/10.2147/ceor.s625089

Source records